喉頭癌に対する選択的動注化学放射線療法

書誌事項

タイトル別名
  • Intra-arterial Chemoradiotherapy for Laryngeal Cancer

この論文をさがす

抄録

Eleven patients who had laryngeal squamous cell carcinoma were treated with intra-arterial chemoradiotherapy between 2004 and 2008 at the Kurume University Hospital. Five of the 11 patients had supraglottic cancer, others had glottic cancer, and 1 had subglottic cancer. Two patients were at Stage II, 7 patients were at Stage III, and 2 patients were at Stage IV A.<BR> The treatment was intra-arterial CDDP (75-100mg⁄body) infusion using the Seldinger method together with irradiation (60-71Gy). All of the patients could be treated with intra-arterial chemoradiotherapy without having to stop the treatment. Complete remission was achieved in all patients, and we have not discovered the recurrence of any tumors yet. The laryngeal preservation rate was 100%. Observed side effects were as follows: 4 patients had Grade I pharyngitis, 2 patients had Grade I dermatitis from irradiation and 1 patient had Grade III pancytopenia. Intra-arterial chemoradiotherapy for laryngeal cancer may be the most effective treatment which allows for laryngeal preservation.

収録刊行物

  • 喉頭

    喉頭 21 (2), 71-77, 2009

    日本喉頭科学会

被引用文献 (4)*注記

もっと見る

参考文献 (12)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ